Tularemia: a re-emerging tick-borne infectious disease

Area of Science:

• Bacteriology
• Infectious Diseases
• Public Health

Background:

• Tularemia is a zoonotic bacterial disease caused by Francisella tularensis, a Gram-negative coccobacillus.
• Recent increases in human tularemia cases have been observed globally, particularly in North America, Scandinavia, and parts of Asia.
• The bacterium can spread through various vectors and exposure routes, including contaminated water, infected animals, and aerosols.

Purpose of the Study:

• To provide a comprehensive overview of tularemia, including its general features.
• To discuss the current status, transmission dynamics, and clinical manifestations of tularemia.
• To highlight the diagnostic methods, treatment options, and the critical need for vaccine development.

Main Methods:

• Literature review focusing on general features, importance, current status, and preventive measures of tularemia.
• Analysis of transmission routes, clinical presentations, and diagnostic approaches.
• Evaluation of current treatment strategies and the unmet need for prophylaxis.

Main Results:

• Tularemia presents with diverse clinical forms (glandular, ulceroglandular, oculoglandular, oropharyngeal, respiratory, typhoidal).
• Diagnosis relies on culture, serology, and molecular methods.
• Effective treatments include quinolones, tetracyclines, and aminoglycosides, but no licensed vaccine is currently available.

Conclusions:

• Tularemia is a significant public health concern due to its increasing incidence and potential as a biological warfare agent.
• Prompt diagnosis and appropriate antibiotic treatment are crucial for managing tularemia cases.
• The development of a licensed tularemia vaccine is a high-priority research area to improve prophylaxis and disease control.